Literature DB >> 21641766

Cognitive processing and acrophobia: validating the Heights Interpretation Questionnaire.

Shari A Steinman1, Bethany A Teachman.   

Abstract

Three studies were conducted to examine the psychometric properties of a new scale: the Heights Interpretation Questionnaire (HIQ). This scale was designed to measure height fear-relevant interpretation bias to help assess the relationship between biased interpretations and acrophobia symptoms. Studies 1 (N=553) and 2 (N=308) established the scale's factor structure and convergent and discriminant validity among two large undergraduate samples. Study 3 (N=48) evaluated the predictive validity of the HIQ by examining how well the scale predicted subjective distress and avoidance on actual heights. Factor analysis resulted in four distinct factors, and results suggest that each of the factors, along with the full HIQ, have good reliability and validity. Additionally, the scale predicts subjective distress and avoidance on heights beyond self-reported acrophobia symptoms. Overall, the HIQ shows promise as a new tool to investigate cognitive processing biases in acrophobia.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21641766      PMCID: PMC3152668          DOI: 10.1016/j.janxdis.2011.05.001

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  11 in total

1.  Virtual reality treatment versus exposure in vivo: a comparative evaluation in acrophobia.

Authors:  P M G Emmelkamp; M Krijn; A M Hulsbosch; S de Vries; M J Schuemie; C A P G van der Mast
Journal:  Behav Res Ther       Date:  2002-05

2.  Spider phobia interaction of disgust and perceived likelihood of involuntary physical contact.

Authors:  Peter J de Jong; Peter Muris
Journal:  J Anxiety Disord       Date:  2002

3.  A new mode of fear expression: perceptual bias in height fear.

Authors:  Bethany A Teachman; Jeanine K Stefanucci; Elise M Clerkin; Meghan W Cody; Dennis R Proffitt
Journal:  Emotion       Date:  2008-04

4.  The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample.

Authors:  Julie D Henry; John R Crawford
Journal:  Br J Clin Psychol       Date:  2005-06

5.  Self-directed desensitization for acrophobia.

Authors:  B L Baker; D C Cohen; J T Saunders
Journal:  Behav Res Ther       Date:  1973-02

6.  Danger expectancies and insight in acrophobia.

Authors:  R G Menzies; J C Clarke
Journal:  Behav Res Ther       Date:  1995-02

7.  Assessment of fear of fear in agoraphobics: the body sensations questionnaire and the agoraphobic cognitions questionnaire.

Authors:  D L Chambless; G C Caputo; P Bright; R Gallagher
Journal:  J Consult Clin Psychol       Date:  1984-12

8.  Augmenting in vivo exposure with fear antagonistic actions: a preliminary test.

Authors:  Kate B Wolitzky; Michael J Telch
Journal:  Behav Ther       Date:  2008-07-02

9.  The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories.

Authors:  P F Lovibond; S H Lovibond
Journal:  Behav Res Ther       Date:  1995-03

10.  Imagery and fear influence height perception.

Authors:  Elise M Clerkin; Meghan W Cody; Jeanine K Stefanucci; Dennis R Proffitt; Bethany A Teachman
Journal:  J Anxiety Disord       Date:  2008-12-09
View more
  14 in total

1.  Effectiveness of Self-guided App-Based Virtual Reality Cognitive Behavior Therapy for Acrophobia: A Randomized Clinical Trial.

Authors:  Tara Donker; Ilja Cornelisz; Chris van Klaveren; Annemieke van Straten; Per Carlbring; Pim Cuijpers; Jean-Louis van Gelder
Journal:  JAMA Psychiatry       Date:  2019-07-01       Impact factor: 21.596

2.  Reaching new heights: comparing interpretation bias modification to exposure therapy for extreme height fear.

Authors:  Shari A Steinman; Bethany A Teachman
Journal:  J Consult Clin Psychol       Date:  2014-03-03

3.  Believing is seeing: Changes in visual perception following treatment for height fear.

Authors:  Sarah E Dreyer-Oren; Elise M Clerkin; Cierra B Edwards; Bethany A Teachman; Shari A Steinman
Journal:  J Behav Ther Exp Psychiatry       Date:  2018-08-03

4.  A New Questionnaire for Estimating the Severity of Visual Height Intolerance and Acrophobia by a Metric Interval Scale.

Authors:  Doreen Huppert; Eva Grill; Thomas Brandt
Journal:  Front Neurol       Date:  2017-06-01       Impact factor: 4.003

5.  0Phobia - towards a virtual cure for acrophobia: study protocol for a randomized controlled trial.

Authors:  T Donker; S Van Esveld; N Fischer; A Van Straten
Journal:  Trials       Date:  2018-08-09       Impact factor: 2.279

6.  Effects of virtual reality high heights exposure during beam-walking on physiological stress and cognitive loading.

Authors:  Steven M Peterson; Emily Furuichi; Daniel P Ferris
Journal:  PLoS One       Date:  2018-07-06       Impact factor: 3.240

7.  Large-Group One-Session Treatment: Feasibility in Highly Height Fearful Individuals and Predictors of Outcome.

Authors:  André Wannemueller; Piotr Gruszka; Sarah Chwalek; Sonja Fröhlich; Miriam Mulders; Svenja Schaumburg; Johanna Schöttes; Sonja Wiederhold; Jürgen Margraf
Journal:  Front Psychol       Date:  2019-10-24

8.  Automated psychological therapy using immersive virtual reality for treatment of fear of heights: a single-blind, parallel-group, randomised controlled trial.

Authors:  Daniel Freeman; Polly Haselton; Jason Freeman; Bernhard Spanlang; Sameer Kishore; Emily Albery; Megan Denne; Poppy Brown; Mel Slater; Alecia Nickless
Journal:  Lancet Psychiatry       Date:  2018-07-11       Impact factor: 27.083

9.  Within- and Between-Session Prefrontal Cortex Response to Virtual Reality Exposure Therapy for Acrophobia.

Authors:  Aleksandra Landowska; David Roberts; Peter Eachus; Alan Barrett
Journal:  Front Hum Neurosci       Date:  2018-11-01       Impact factor: 3.169

Review 10.  Height intolerance between physiological mechanisms and psychological distress: a review of literature and our experience.

Authors:  R Teggi; F Comacchio; F Fornasari; E Mira
Journal:  Acta Otorhinolaryngol Ital       Date:  2019-08       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.